X0708 D LIVE 0001445283 KINETA, INC./DE 219 TERRY AVE. N. SUITE 300 SEATTLE WA WASHINGTON 98109 (206) 378-0400 DELAWARE YUMANITY THERAPEUTICS, INC. PROTEOSTASIS THERAPEUTICS, INC. PROTEOSTASIS THERAPEUTICS INC Corporation true Shawn P. Iadonato c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Director Craig W. Philips c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Keith A. Baker c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Thierry Guillaudeux c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Pauline Kenny c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Marion R. Foote c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director Raymond Bartoszek c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director Richard Peters c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director David Arkowitz c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director Kimberlee C. Drapkin c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director Scott J. Dylla c/o Kineta, Inc. 219 Terry Ave. N., Suite 300 Seattle WA WASHINGTON 98109 Director Biotechnology Decline to Disclose 06b false 2023-10-03 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue 3rd Floor New York NY NEW YORK 10022 NY NEW YORK false 2893176 0 2893176 Concurrent with a registered offering, warrants were issued to purchase up to an aggregate of 890,208 shares of common stock at $3.25 per share. Gross proceeds will come from the exercise of the warrants to the extent such warrants are exercised for cash. false 1 210000 0 Represents the 7% cash fee paid to the placement agent in the concurrent registered direct offering referenced in item 13. 0 false KINETA, INC./DE /s/ Pauline Kenny Pauline Kenny General Counsel & Secretary 2023-10-20